학술논문

Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2
Document Type
Article
Source
In: Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. (Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, 2023, 123(4):37-47)
Subject
Language
English
ISSN
23094729
19977298